Evidence method
Level · gp.fundamentals.debt_to_revenue
122.78% · OPTIONAL · NOT_ENOUGH_HISTORY
STANDARD BIOTOOLS INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
122.78% · OPTIONAL · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.capex_revenue_ratio
5.01% · OPTIONAL · NOT_ENOUGH_HISTORY
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-61.97% · OPTIONAL · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.inventory_revenue_ratio
94.83% · OPTIONAL · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.gross_margin
51.73% · CORE · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.operating_margin
-70.53% · CORE · NOT_ENOUGH_HISTORY
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
29.26% · OPTIONAL · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.sbc_revenue_ratio
13.17% · OPTIONAL · NOT_ENOUGH_HISTORY
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.